Narendranath Epperla
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 91
- Oncology 62
- CAR-T cell therapy research 34
- Viral-associated cancers and disorders 19
- Co-authors
- Mehdi Hamadani (29 shared papers)Walter Hanel (16 shared papers)Timothy S. Fenske (18 shared papers)William G. Hocking (1 shared paper)Apoorva Jayarangaiah (3 shared papers)Fergus McKiernan (1 shared paper)Lisa Baumann Kreuziger (2 shared papers)John L. Vaughn (10 shared papers)
- Journals
- Blood (40 papers)Blood Advances (10 papers)Hematological Oncology (9 papers)Clinical Medicine & Research (7 papers)British Journal of Haematology (5 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Narendranath Epperla
141 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 76
- Pathology and Forensic Medicine 454
- Genetics 248
- Transplantation 52
- Oncology 428
- Hematology 105
Countries citing papers authored by Narendranath Epperla
This map shows the geographic impact of Narendranath Epperla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narendranath Epperla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narendranath Epperla more than expected).
Fields of papers citing papers by Narendranath Epperla
This network shows the impact of papers produced by Narendranath Epperla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narendranath Epperla. The network helps show where Narendranath Epperla may publish in the future.
Co-authors
The 25 scholars most cited alongside Narendranath Epperla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 59 | |
| 2 | 2017 | 49 | |
| 3 | 2016 | 44 | |
| 4 | 2018 | 36 | |
| 5 | 2020 | 36 | |
| 6 | 2014 | 30 | |
| 7 | 2014 | 29 | |
| 8 | 2017 | 27 | |
| 9 | 2015 | 26 | |
| 10 | 2017 | 26 | |
| 11 | 2019 | 23 | |
| 12 | 2018 | 21 | |
| 13 | 2020 | 21 | |
| 14 | 2021 | 21 | |
| 15 | 2024 | 21 | |
| 16 | 2019 | 21 | |
| 17 | Mirtazapine and mefloquine therapy for non-AIDS-related progressive multifocal leukoencephalopathy. | 2014 | 21 |
| 18 | 2023 | 20 | |
| 19 | 2017 | 17 | |
| 20 | 2020 | 17 |
About Narendranath Epperla
Narendranath Epperla is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Immunology and Neurology, having authored 159 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (91 papers), Chronic Lymphocytic Leukemia Research (40 papers), CAR-T cell therapy research (34 papers), Viral-associated cancers and disorders (19 papers), CNS Lymphoma Diagnosis and Treatment (17 papers), Acute Lymphoblastic Leukemia research (14 papers), Immune Cell Function and Interaction (8 papers) and Multiple and Secondary Primary Cancers (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (454 citations), Genetics (248 citations), Transplantation (52 citations), Oncology (428 citations) and Hematology (105 citations). Narendranath Epperla has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Mehdi Hamadani, Walter Hanel, Timothy S. Fenske, William G. Hocking, Apoorva Jayarangaiah, Fergus McKiernan, Lisa Baumann Kreuziger, John L. Vaughn, Joseph J. Mazza and Nathan Denlinger. Their work appears in journals such as Blood, Blood Advances, Hematological Oncology, Clinical Medicine & Research and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.